Allopurinol and the Risk of Diabetic Macular Edema among U.S. Veterans with Type 2 Diabetes
{{output}}
Background: By inhibiting xanthine oxidase, subsequent inflammatory cytokine release and the resulting breakdown of the blood-retina barrier, allopurinol may limit the inflammation-driving diabetic macular edema (DME). ... ...
